[go: up one dir, main page]

AU2003242965B2 - Composition and methods for the treatment of skin disorders - Google Patents

Composition and methods for the treatment of skin disorders Download PDF

Info

Publication number
AU2003242965B2
AU2003242965B2 AU2003242965A AU2003242965A AU2003242965B2 AU 2003242965 B2 AU2003242965 B2 AU 2003242965B2 AU 2003242965 A AU2003242965 A AU 2003242965A AU 2003242965 A AU2003242965 A AU 2003242965A AU 2003242965 B2 AU2003242965 B2 AU 2003242965B2
Authority
AU
Australia
Prior art keywords
vitamin
cells
nicotinamide
epidermal
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003242965A
Other languages
English (en)
Other versions
AU2003242965A1 (en
Inventor
Olga Bloch
Avikam Harel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dermipsor Ltd
Original Assignee
Dermipsor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/192,842 external-priority patent/US20030032617A1/en
Application filed by Dermipsor Ltd filed Critical Dermipsor Ltd
Publication of AU2003242965A1 publication Critical patent/AU2003242965A1/en
Application granted granted Critical
Publication of AU2003242965B2 publication Critical patent/AU2003242965B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003242965A 2002-07-11 2003-07-10 Composition and methods for the treatment of skin disorders Ceased AU2003242965B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/192,842 US20030032617A1 (en) 2000-01-11 2002-07-11 Composition and methods for the treatment of skin disorders
US10/192,842 2002-07-11
PCT/IL2003/000576 WO2004006887A2 (fr) 2002-07-11 2003-07-10 Compositions et methodes pour le traitement de troubles cutanes

Publications (2)

Publication Number Publication Date
AU2003242965A1 AU2003242965A1 (en) 2004-02-02
AU2003242965B2 true AU2003242965B2 (en) 2009-02-05

Family

ID=30114413

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003242965A Ceased AU2003242965B2 (en) 2002-07-11 2003-07-10 Composition and methods for the treatment of skin disorders

Country Status (4)

Country Link
EP (1) EP1539100A4 (fr)
AU (1) AU2003242965B2 (fr)
CA (1) CA2492248A1 (fr)
WO (1) WO2004006887A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7977049B2 (en) * 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
US20050288310A1 (en) * 2004-06-04 2005-12-29 Chemgenex Pharmaceuticals, Inc. Methods of treating cellular proliferative disease using naphthalimide and PARP-1 inhibitors
JP2008540513A (ja) * 2005-05-10 2008-11-20 ダーミプソル リミテッド スキンケアのための組成物及び方法
CN101193641B (zh) 2005-05-10 2013-05-29 德米普瑟尔有限公司 用于治疗表皮过度增殖疾病的组合物和方法
US9877981B2 (en) 2012-10-09 2018-01-30 President And Fellows Of Harvard College NAD biosynthesis and precursors for the treatment and prevention of cancer and proliferation
CN108836965A (zh) * 2018-08-07 2018-11-20 浙江大学 尼克酰胺组合物在制备治疗索拉非尼手足皮肤反应药物中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067975A (en) * 1975-08-04 1978-01-10 Yu Ruey J Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide
US5430049A (en) * 1993-12-08 1995-07-04 Gaut; Zane N. Treating hyperproliferative disorders
WO1998052529A1 (fr) * 1997-05-23 1998-11-26 The Procter & Gamble Company Compositions pour les soins de la peau, comprenant de la vitamine b3 et un constituant de revitalisation de la peau
WO2001051051A2 (fr) * 2000-01-11 2001-07-19 Avikam Harel Agents de traitement des troubles cutanes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
US5831074A (en) * 1988-11-02 1998-11-03 Strumwasser; Felix Eucaryotic NAD cyclases
JPH05163160A (ja) * 1991-12-13 1993-06-29 Snow Brand Milk Prod Co Ltd 免疫低下に伴う感染症の予防及び治療用栄養剤
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum
DE29916231U1 (de) * 1999-09-15 2000-02-17 Renner, Jobst, Dr., 81479 München Multivitamin- und -mineralpräparat

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067975A (en) * 1975-08-04 1978-01-10 Yu Ruey J Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide
US5430049A (en) * 1993-12-08 1995-07-04 Gaut; Zane N. Treating hyperproliferative disorders
WO1998052529A1 (fr) * 1997-05-23 1998-11-26 The Procter & Gamble Company Compositions pour les soins de la peau, comprenant de la vitamine b3 et un constituant de revitalisation de la peau
WO2001051051A2 (fr) * 2000-01-11 2001-07-19 Avikam Harel Agents de traitement des troubles cutanes

Also Published As

Publication number Publication date
AU2003242965A1 (en) 2004-02-02
CA2492248A1 (fr) 2004-01-22
WO2004006887A3 (fr) 2004-03-18
EP1539100A2 (fr) 2005-06-15
EP1539100A4 (fr) 2006-01-18
WO2004006887A2 (fr) 2004-01-22

Similar Documents

Publication Publication Date Title
US20030032617A1 (en) Composition and methods for the treatment of skin disorders
EP1879595B1 (fr) Compositions et methodes pour traiter des maladies epidermiques hyperproliferatives
AU666949B2 (en) Compositions containing retinoic acids and tocopherol
EP3325487B1 (fr) Préparation pour analogues d'anticholinergiques à potentiel modéré
AU2024227714A1 (en) Formulation for soft anticholinergic analogs
AU2003242965B2 (en) Composition and methods for the treatment of skin disorders
US20150202187A1 (en) Compositions and methods for treatment of vitiligo
US20160220589A1 (en) Compositions and methods for the treatment of skin disorders
IL102344A (en) Use of vitamin d3, its analogues, derivatives and active metabolites for the manufacture of medicaments for stimulating hair growth in humans and warm blooded animals
US20250241937A1 (en) Cancer cell proliferation suppression agent and composition for suppressing proliferation of cancer cells
IE64186B1 (en) Dehydrocholecalciferol derivatives
IL150706A (en) Combinations of nicotinamide and vitamin d agents and use thereof in preparation of compositions for the treatment of skin disorders
US11491134B2 (en) Composition for inhibiting skin cell proliferation and/or anti-inflammation method for inhibiting skin cell proliferation and/or anti-inflammation and method for treating skin diseases and/or inflammatory diseases
US20220296610A1 (en) Compositions and methods for treatment of infection and novel cosmeceutical preparations
AU2020282051B2 (en) Composition containing fluoxetine and vitamin D 3 or its derivatives and application thereof
HK1051497B (en) Agents, such as nicotinamide or cadpr for the treatment of skin disorders
CN119345052A (zh) 青蒿酸的抗糖化应用
EP0754447A1 (fr) Composition cosmétique pour la peau
CN116350531A (zh) 猫眼草酚d的抗糖化应用
CN119345164A (zh) 紫萁酮的抗炎舒缓功效及其应用
HK40096836A (en) Formulation for soft anticholinergic analogs
US20220211605A1 (en) Agent for protection against atmospheric pollutants and composition for protection against atmospheric pollutants
HK1251564B (en) Formulation for soft anticholinergic analogs

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired